20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T22394 | Paritaprevir | ABT450,ABT-450,Veruprevir | HCV Protease |
Paritaprevir (ABT450) is an inhibitor of non-structural protein 3/4A protease with EC50 values of 1 and 0.21 nM for HCV 1a and HCV 1b, respectively. | |||
T5938 | 4-Phenoxybenzylamine | HCV Protease | |
4-Phenoxybenzylamine inhibits the function of the NS3 protein by stabilizing an inactive conformation with an IC50 of about 500 μM against HCV NS3/4a . | |||
T6190 | Telaprevir | VX-950,LY-570310,Incivek,MP-424 | HCV Protease , SARS-CoV |
Telaprevir (Incivek) (VX-950) is an effective inhibitor of HCV NS3-4A serine protease (IC50: 0.35 μM). | |||
T5126 | Glecaprevir | ABT-493 | HCV Protease , SARS-CoV |
Glecaprevir (ABT-493) is an HCV NS3/4A protease inhibitor, (IC50s: 3.5-11.3 nM). | |||
T4197 | HZ-1157 | HZ1157,DHFR-inhibitor | HCV Protease |
HZ-1157 (DHFR-inhibitor) is a hepatitis C virus (HCV) inhibitor with inhibitory activities toward HCV NS3/4A protease. | |||
T6025 | Danoprevir | R7227,ITMN-191,RG7227,RO5190591 | HCV Protease , SARS-CoV |
Danoprevir (RG7227) is a peptidomimetic inhibitor of the NS3/4A protease(IC50=0.2-3.5 nM) of hepatitis C virus (HCV). | |||
T4686 | Simeprevir | TMC435,TMC-435350,Olysio | HCV Protease , SARS-CoV |
Simeprevir (TMC435) is a potent HCV NS3/4A protease inhibitor, and inhibits HCV replication with EC50 of 8 nM. | |||
T4547 | Grazoprevir | MK-5172 | HCV Protease , SARS-CoV |
Grazoprevir (MK-5172) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Ki of 0.01 nM (gt1a), 0.08 nM (gt2a), 0.90 nM (gt3a), 0.01 nM (gt1b), ... | |||
T19862 | Voxilaprevir | HCV Protease | |
Voxilaprevir is an inhibitor of hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease. | |||
T3226 | Paritaprevir | ABT-450,Veruprevir | HCV Protease |
Paritaprevir (ABT-450) is an orally bioavailable, synthetic acylsulfonamide inhibitor of the hepatitis C virus (HCV) protease complex comprised of non-structural protein 3 and 4A (NS3/NS4A), with potential activity again... | |||
T8675 | Vaniprevir | Others | |
Vaniprevir is a macrocyclic hepatitis C virus NS3/4a protease inhibitor and is active against both the genotype 1 and genotype 2 NS3/4a protease enzymes. vaniprevir has good plasma exposure and excellent liver exposure... | |||
T71031 | Deldeprevir Na | ||
Deldeprevir Na is an Antiviral Polyprotein cleavage inhibitor. HCV NS3/4A inhibitor. | |||
T70655 | Furaprevir | ||
Furaprevir is an HCV NS3/4A Inhibitor | |||
T11540 | HCV-IN-3 | Others | |
HCV-IN-3 is a hepatitis C virus (HCV) NS3/4a protein inhibitor (IC50: 20 μM; Kd: 29 μM). | |||
T68354 | Danoprevir sodium | ||
Danoprevir sodium is an NS3/4A protease inhibitor used in the treatment of Hepatitis C | |||
T68335 | MK-1220 | ||
MK-1220 is a novel Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure. | |||
T12065 | Grazoprevir sodium salt | MK-5172 (sodium salt) | Others |
Grazoprevir sodium salt is a selective Hepatitis C virus NS3/4a protease inhibitor with broad activity across genotypes and resistant variants. | |||
T19948 | Grazoprevir potassium salt | MK 5172 potassium,Grazoprevir,Grazoprevir potassium,MK 5172,MK5172,MK-5172 | |
Grazoprevir is a drug approved for the treatment of hepatitis C. Grazoprevir is a second-generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets. | |||
T21456 | Grazoprevir hydrate | Grazoprevir,MK5172,MK 5172,MK-5172 | |
Grazoprevir, a second generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets, has good activity against a range of hepatitis C virus genotype variants, including some that are resistant to ... | |||
T73898 | Paritaprevir dihydrate | ||
Paritaprevir dihydrate (ABT-450), a highly effective and orally administered antiviral, acts as a non-structural protein 3/4A (NS3/4A) protease inhibitor, displaying EC50 values of 1 and 0.21 nM against HCV genotypes 1a ... |